LRP1 and metabolic syndrome: This study is, to our knowledge, the first to report that Lrp1 is a co-activator of Pparγ and that depletion of Lrp1 in endothelium regulates global energy homeostasis and alleviates some metabolic syndromes, such as obesity and insulin resistance.